Organogenesis Holdings Inc.
NASDAQ:ORGO
3.19 (USD) • At close December 27, 2024
Overview | Financials
Numbers are in millions (except for per share data and ratios) USD.
2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | |
---|---|---|---|---|---|---|---|---|---|
Assets: | |||||||||
Current Assets: | |||||||||
Cash & Cash Equivalents
| 104.338 | 102.478 | 113.929 | 84.394 | 60.174 | 21.291 | 0.126 | 1.04 | 0.126 |
Short Term Investments
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Cash and Short Term Investments
| 104.338 | 102.478 | 113.929 | 84.394 | 60.174 | 21.291 | 0.126 | 1.04 | 0.126 |
Net Receivables
| 81.999 | 89.45 | 82.46 | 56.804 | 39.359 | 34.077 | 0 | 0 | 0 |
Inventory
| 28.253 | 24.783 | 25.022 | 27.799 | 22.918 | 13.321 | 0 | 0 | 0 |
Other Current Assets
| 10.454 | 5.898 | 5.568 | 5.347 | 3.149 | 2.442 | 0.169 | 0.396 | 0 |
Total Current Assets
| 225.044 | 222.609 | 226.979 | 174.344 | 125.6 | 71.131 | 0.294 | 1.436 | 0.126 |
Non-Current Assets: | |||||||||
Property, Plant & Equipment, Net
| 156.346 | 145.655 | 128.304 | 60.068 | 47.184 | 39.623 | 0 | 0 | 0 |
Goodwill
| 28.772 | 28.772 | 28.772 | 28.772 | 25.539 | 25.539 | 0 | 0 | 0 |
Intangible Assets
| 15.871 | 20.789 | 25.673 | 30.622 | 20.797 | 26.091 | 0 | 0 | 0 |
Goodwill and Intangible Assets
| 44.643 | 49.561 | 54.445 | 59.394 | 46.336 | 51.63 | 0 | 0 | 0 |
Long Term Investments
| 0 | 0 | 0 | 0 | 0.556 | 0.477 | 312.498 | 310 | 0 |
Tax Assets
| 28.002 | 30.014 | 31.994 | 0.018 | 0.127 | 0.238 | 0 | 0 | 0 |
Other Non-Current Assets
| 5.99 | 1.52 | 1.537 | 0.67 | 0.884 | 0.579 | 0 | 0 | 0.29 |
Total Non-Current Assets
| 234.981 | 226.75 | 216.28 | 120.15 | 95.087 | 92.547 | 312.498 | 310 | 0.29 |
Total Assets
| 460.025 | 449.359 | 443.259 | 294.494 | 220.687 | 163.678 | 312.792 | 311.436 | 0.416 |
Liabilities & Equity: | |||||||||
Current Liabilities: | |||||||||
Account Payables
| 30.724 | 32.33 | 29.339 | 23.381 | 28.387 | 19.165 | 19.053 | 0 | 0 |
Short Term Debt
| 33.936 | 16.246 | 26.626 | 20.285 | 6.114 | 4.781 | 5.469 | 0 | 0.175 |
Tax Payables
| 2.799 | 2.625 | 1.16 | 0 | 0 | 0 | 0 | 0 | 0 |
Deferred Revenue
| 0 | 0 | 35.722 | 22.492 | 22.64 | 30.415 | 0 | 0 | 0 |
Other Current Liabilities
| 13.05 | 23.822 | 25.58 | 24.551 | 25.393 | 37.442 | -20.593 | 0.478 | 0.241 |
Total Current Liabilities
| 80.509 | 75.023 | 82.005 | 68.217 | 59.894 | 66.388 | 3.929 | 0.478 | 0.416 |
Non-Current Liabilities: | |||||||||
Long Term Debt
| 99.64 | 107.545 | 117.662 | 57.54 | 97.549 | 49.216 | 12.39 | 0 | 0 |
Deferred Revenue Non-Current
| 0 | 0 | 0 | 2.315 | 1.012 | 0.13 | 0 | 0 | 0 |
Deferred Tax Liabilities Non-Current
| 0 | 0 | 0 | -2.315 | -1.012 | 0 | 0 | 0 | 0 |
Other Non-Current Liabilities
| 1.213 | 1.122 | 1.557 | 20.338 | 7.661 | 0.903 | -1.54 | 10.85 | 0 |
Total Non-Current Liabilities
| 100.853 | 108.667 | 119.219 | 80.193 | 105.21 | 50.249 | 10.85 | 10.85 | 0.175 |
Total Liabilities
| 181.362 | 183.69 | 201.224 | 148.41 | 165.104 | 116.637 | 14.779 | 11.328 | 0.416 |
Equity: | |||||||||
Preferred Stock
| 0 | 0 | 0 | 0 | 0 | 0 | 293.014 | 295.108 | 0 |
Common Stock
| 0.013 | 0.013 | 0.013 | 0.013 | 0.01 | 0.009 | 293.015 | 295.108 | 0.001 |
Retained Earnings
| -40.971 | -45.301 | -60.133 | -153.058 | -171.007 | -130.24 | -2.328 | -0.234 | -0.025 |
Accumulated Other Comprehensive Income/Loss
| 0 | 0 | 0 | 0 | 0 | 0 | -293.014 | -295.108 | 0 |
Other Total Stockholders Equity
| 319.621 | 310.957 | 302.855 | 296.83 | 226.58 | 177.272 | 300.34 | 300.34 | 0.024 |
Total Shareholders Equity
| 278.663 | 265.669 | 242.035 | 146.084 | 55.583 | 47.041 | 298.014 | 300.108 | -0 |
Total Equity
| 278.663 | 265.669 | 242.035 | 146.084 | 55.583 | 47.041 | 298.014 | 300.108 | -0 |
Total Liabilities & Shareholders Equity
| 460.025 | 449.359 | 443.259 | 294.494 | 220.687 | 163.678 | 312.792 | 311.436 | 0.416 |